Reply to Chopra and Rizvi

Clin Infect Dis. 2019 Sep 13;69(7):1265-1266. doi: 10.1093/cid/ciz128.

Authors

Sumanth Gandra¹, Anita Arora², Ramanan Laxminarayan^{1

3

4}, Eili Y Klein^{1

5

6}

Affiliations

¹ Center for Disease Dynamics, Economics & Policy, Washington, DC.
² Fortis Healthcare Ltd., Gurgaon, Haryana, India.
³ Princeton Environmental Institute, Princeton University, New Jersey.
⁴ Department of Global Health, University of Washington, Seattle.
⁵ Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
⁶ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Drug Resistance, Multiple*
India
Infections* / mortality
Mortality / trends
Retrospective Studies